Bladder Carcinoma — Trials

Bladder Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

332 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 141
Recruiting: 74
Ph III recruiting: 14
Growth YoY: +6.5%
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 48.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (49)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03039413	Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy	completed	Early Phase 1	20	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER	1	Aug 22, 2025	clinicaltrials
NCT03473730	Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer	completed	Early Phase 1	17	M.D. Anderson Cancer CenterOTHER	1	Jan 30, 2025